We are live on
!
Find out more
UOC
UBS O'Connor Portfolio holdings
AUM
$3.76B
1-Year Est. Return
62.41%
This Fund
S&P 500
This Quarter
Est. Return
+13.06%
1 Year Est. Return
+62.41%
3 Year Est. Return
+179.84%
5 Year Est. Return
+371.69%
10 Year Est. Return
+1,534.25%
AUM
$4.23B
AUM Growth
+$208M
(+5.2%)
Cap. Flow
+$22.5M
Cap. Flow
% of AUM
0.53%
Top 10 Holdings %
Top 10 Hldgs %
66.8%
Holding
503
New
83
Increased
81
Reduced
97
Closed
181
Avg Time Held Equity + Options
4.4
quarters
Top 10 Avg Time Held Equity + Options
1.5
quarters
Top 20 Avg Time Held Equity + Options
1.6
quarters
Avg Time Held Equity only
4.5
quarters
Top 10 Avg Time Held Equity only
1.5
quarters
Top 20 Avg Time Held Equity only
1.6
quarters
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Intra-Cellular Therapies Inc.
ITCI
|
+$383M |
| 2 |
Discover Financial Services
DFS
|
+$224M |
| 3 |
Beacon Roofing Supply, Inc.
BECN
|
+$183M |
| 4 |
Walgreens Boots Alliance
WBA
|
+$110M |
| 5 |
Nordstrom
JWN
|
+$95.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
HashiCorp, Inc. Class A Common Stock
HCP
|
+$235M |
| 2 |
Smartsheet Inc.
SMAR
|
+$216M |
| 3 |
Endeavor Group Holdings, Inc.
EDR
|
+$144M |
| 4 |
Summit Materials, Inc. Class A Common Stock
SUM
|
+$103M |
| 5 |
Altair Engineering Inc
ALTR
|
+$97.9M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Energy | 17.21% |
| 2 | Healthcare | 16.93% |
| 3 | Financials | 12.93% |
| 4 | Industrials | 12.5% |
| 5 | Technology | 10.61% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
276
CALL
Energy Transfer Partners
ET
$69.7B
| $49.6K | ﹤0.01% |
+320,000
| New | +$6.23M |
2025 Q1
0 quarters
|
|
277
Veru
VERU
$41.1M
| $49.5K | ﹤0.01% |
10,102
-22,884
| -69% | -$142K |
2023 Q4
5 quarters
|
|
278
CALL
Magnite
MGNI
$3.59B
| $48.1K | ﹤0.01% |
107,000
| – | – |
2024 Q3
2 quarters
|
|
279
Inovio Pharmaceuticals
INO
$115M
| $47.9K | ﹤0.01% |
29,375
-195,625
| -87% | -$393K |
2024 Q4
1 quarter
|
|
280
PUT
FirstEnergy
FE
$26.2B
| $44.9K | ﹤0.01% |
26,000
| – | – |
2024 Q2
3 quarters
|
|
281
Context Therapeutics
CNTX
$27.2M
| $41.4K | ﹤0.01% |
67,631
-241,127
| -78% | -$210K |
2023 Q2
7 quarters
|
|
282
CALL
Celanese
CE
$4.94B
| $40.3K | ﹤0.01% |
+70,000
| New | +$4.37M |
2025 Q1
0 quarters
|
|
283
PepGen
PEPG
$175M
| $37.3K | ﹤0.01% |
+26,559
| New | +$54.7K |
2025 Q1
0 quarters
|
|
284
DELISTED
Mersana Therapeutics
MRSN
| $33.6K | ﹤0.01% |
3,909
-12,492
| -76% | -$193K |
2023 Q3
6 quarters
|
|
285
PUT
Vornado Realty Trust
VNO
$6.3B
| $32.7K | ﹤0.01% |
33,500
| – | – |
2024 Q2
3 quarters
|
|
286
DELISTED
Inozyme Pharma
INZY
| $31.7K | ﹤0.01% |
34,788
-166,444
| -83% | -$231K |
2022 Q2
11 quarters
|
|
287
Acrivon Therapeutics
ACRV
$81.8M
| $31.6K | ﹤0.01% |
15,576
-87,208
| -85% | -$470K |
2023 Q2
7 quarters
|
|
288
PUT
DELISTED
Blueprint Medicines
BPMC
| $30.8K | ﹤0.01% |
+10,000
| New | +$976K |
2025 Q1
0 quarters
|
|
289
CALL
uniQure
QURE
$1.53B
| $29.3K | ﹤0.01% |
65,000
-50,000
| -43% | -$701K |
2024 Q4
1 quarter
|
|
290
PUT
Procept Biorobotics
PRCT
$1.12B
| $27.4K | ﹤0.01% |
+15,000
| New | +$1.02M |
2025 Q1
0 quarters
|
|
291
PUT
Occidental Petroleum
OXY
$61.3B
| $24.6K | ﹤0.01% |
+90,000
| New | +$4.39M |
2025 Q1
0 quarters
|
|
292
CALL
Carnival Corporation Ltd
CCL
$35.8B
| $24K | ﹤0.01% |
+150,000
| New | +$3.57M |
2025 Q1
0 quarters
|
|
293
Kodiak AI Warrants
KDKRW
| $23.6K | ﹤0.01% |
82,711
| – | – |
2023 Q4
5 quarters
|
|
294
Sutro Biopharma
STRO
$219M
| $18.4K | ﹤0.01% |
2,828
-27,234
| -91% | -$429K |
2023 Q3
6 quarters
|
|
295
CALL
Akamai
AKAM
$14.7B
| $14.1K | ﹤0.01% |
+37,500
| New | +$3.36M |
2025 Q1
0 quarters
|
|
296
Nektar Therapeutics
NKTR
$1.37B
| $13.5K | ﹤0.01% |
1,328
-104,066
| -99% | -$1.36M |
2023 Q3
6 quarters
|
|
297
Alliance Entertainment Holding Corp Warrants
AENTW
$1.53M
| $13.4K | ﹤0.01% |
60,000
-54,255
| -47% | -$15.6K |
2023 Q2
7 quarters
|
|
|
XAGEW
298
DELISTED
Longevity Health Holdings, Inc. Warrant
XAGEW
| $13.4K | ﹤0.01% |
371,250
| – | – |
2023 Q3
6 quarters
|
|
299
PUT
Cooper Companies
COO
$10.5B
| $9.38K | ﹤0.01% |
15,000
+3,000
| +25% | +$269K |
2024 Q4
1 quarter
|
|
300
Tevogen Inc Warrant
TVGNW
$1.35M
| $8.98K | ﹤0.01% |
181,387
| – | – |
2022 Q1
12 quarters
|
|
Similar funds
FNBT
ACI
RC
A
CGL
CB
JCM
MPM
UBS O'Connor's Q1 2025 Portfolio in Review
As of Q1 2025, UBS O'Connor held 503 positions worth $4.23B, up 5.2% from $4.02B the previous quarter. Its ten largest holdings account for 67% of the portfolio.
UBS O'Connor's Q1 2025 filing shows 83 new, 81 increased, 97 reduced and 181 closed positions. Its largest new stake was Beacon Roofing Supply, Inc.: 1,575,016 shares worth $195M. The largest sale was HashiCorp, Inc. Class A Common Stock, an estimated $235M.
By sector, the portfolio is most concentrated in Energy at 17% of assets, up from 16% a quarter earlier, followed by Healthcare and Financials.
- UBS O'Connor's largest Q1 2025 buy was Beacon Roofing Supply, Inc.: 1,575,016 shares worth $195M.
- UBS O'Connor added most to Intra-Cellular Therapies Inc. in Q1 2025, an estimated $383M increase.
- UBS O'Connor's biggest Q1 2025 reduction was Juniper Networks, cutting an estimated $71.4M.
- UBS O'Connor fully exited HashiCorp, Inc. Class A Common Stock in Q1 2025, selling an estimated $235M.
- UBS O'Connor's ten largest holdings make up 67% of its $4.23B portfolio in Q1 2025.
- UBS O'Connor opened 83 new positions and closed 181 in Q1 2025.
- UBS O'Connor's portfolio value rose 5.2% quarter-over-quarter to $4.23B.
Based on UBS O'Connor's 13F filing for Q1 2025, filed 15 May 2025.